SEC Form D filing

Pillar Therapeutics, Inc.

Biotech · Series B · Regulation D 506(b) · MA · Filed May 13, 2026

Offering amount
$25.0M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
May 13, 2026
Signature date
—
CIK
0002133041

Summary

Pillar Therapeutics MA $25M; therapeutics/biotech, series-B stage.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.